← Back to Ridgetech Stock
Ridgetech (RDGT) News
HANGZHOU, China , June 11, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1,980,000 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for an aggregate gross proceeds of approximately $3.37 million. The closing of the sale of the securities is expected to occur on or about June 26, 2024, subject to satisfaction of customary closing conditions.
No summary available.
HANGZHOU, China , May 31, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that Ms. Pingfan Wu has resigned from her position as a member of the board of directors (the "Board") due to personal reasons, effective on May 31, 2024.
HANGZHOU, China, May 10, 2024/ PRNewswire/-- China Jo-Jo Drugstores, Inc., a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1.61 million ordinary…
HANGZHOU, China , May 10, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1.61 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $2.74 million. The closing of the sale of the securities is expected to occur on or about May 17, 2024, subject to satisfaction of customary closing conditions.
China Jo-Jo Drugstores Inc (NASDAQ: CJJD ) shares are trading lower by 24% to $2.21 during Monday’s session after the company announced a $1.53 million registered direct offering . The company finalized agreements with multiple investors for a registered direct offering, issuing 0.9 million ordinary shares at $1.70 per share, totaling around $1.53 million in gross proceeds. The sale is set to close around April 30, pending standard closing conditions. The company plans to utilize the net proceeds for general corporate needs and working capital. See Also: … Full story available on Benzinga.com
HANGZHOU, China , April 29, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 0.9 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $1.53 million. The closing of the sale of the securities is expected to occur on or about April 30, 2024, subject to satisfaction of customary closing conditions.
https://www.investing.com/news/stock-market-news/china-jojo-drugstores-meets-nasdaq-minimum-bid-price-93CH-3344729
HANGZHOU, China , March 19, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on March 15, 2024, notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement and the matter is closed. On June 15, 2023, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until December 12, 2023 to regain compliance.
No summary available.